Adverse events · children aged up to 16 years with ARTIs
1 finding from 1 review
Recurrence of ARTI · children aged up to 16 years with ARTIs
Homeopathic medicinal products (individualised treatment) showed no clear difference in recurrence of ARTI compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Days off work for parents · children aged up to 16 years with ARTIs
Homeopathic medicinal products (individualised treatment) showed no clear difference in days off work for parents compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Need for antibiotics · children aged up to 16 years with ARTIs
Homeopathic medicinal products (individualised treatment) showed no clear difference in need for antibiotics compared with placebo or usual care (low certainty).
1 finding from 1 review
Adverse events · children aged up to 16 years with ARTIs
Homeopathic medicinal products (individualised treatment) showed no clear difference in adverse events compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Disease severity · children aged up to 16 years with ARTIs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrence of ARTI · children aged up to 16 years with ARTIs
Homeopathic medicinal products (non‐individualised treatment) showed no clear difference in recurrence of ARTI compared with placebo or usual care (low certainty).
1 finding from 1 review
Days off work for parents · children aged up to 16 years with ARTIs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for antibiotics · children aged up to 16 years with ARTIs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Comparison (intervention vs comparator)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of bleeding Total bleeding in 90 days (bleeding calendar)
1 finding from 1 review
Comparison (intervention vs comparator)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss PBAC score
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Nausea
Mefanamic acid showed no clear difference in side effects: nausea compared with vitex agnus; GRADE not reported.
1 finding from 1 review
OR 1 [0.06, 16.53]
1 participants
GRADE not reported
Abdominal pain
Mefanamic acid showed no clear difference in side effects: abdominal pain compared with vitex agnus; GRADE not reported.
1 finding from 1 review
OR 0.33 [0.01, 8.22]
0 participants
GRADE not reported
Pelvic pain
It is very uncertain whether tranexamic acid changes pelvic pain compared with sodium diclofenac (very low certainty).
1 finding from 1 review
Naproxen vs placebo
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relief of pain
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale)
1 finding from 1 review
Additional analgesia required (escape analgesia)
Naproxen showed no clear difference in need for additional analgesia (self‐recorded) compared with placebo (low certainty).
1 finding from 1 review